Compliance Rate

Compliance Rate 66.0%
Compliant submissions 66
Incompliant submissions 34
Total trials 100

Your Clinical Trials

Showing 100 of 100 entries
View as:

A Clinical Trial To Evaluate the Toxicity and Antiviral Effects of a Range of Doses of Ampligen in p24 Antigen Positive HIV-Infected Patients With AIDS or ARC

Phase: N/A Priority: Normal
NCT ID: NCT00000735 Org: User:
Start: - End: 02/28/90 Due: 02/28/91

Evaluation of a Desipramine Ceiling in Cocaine Abuse - 1

Phase: N/A Priority: Normal
NCT ID: NCT00000245 Org: User:
Start: 05/31/94 End: 12/31/01 Due: 12/31/02

Alternate-Day Buprenorphine Administration. Phase VI - 7

Phase: N/A Priority: Normal
NCT ID: NCT00000225 Org: User:
Start: 12/31/92 End: - Due: -

Evaluation of Subcutaneous Desferrioxamine as Treatment for Transfusional Hemochromatosis

Phase: N/A Priority: Normal
NCT ID: NCT00000595 Org: User:
Start: 01/31/78 End: 09/30/94 Due: 09/30/95

Prevention of Early Readmission in Elderly Congestive Heart Failure Patients

Phase: N/A Priority: Normal
NCT ID: NCT00000475 Org: User:
Start: 04/30/90 End: 03/31/95 Due: 03/31/96

A Study to Evaluate High Protein Supplementation in HIV-Positive Patients With Stable Weight Loss

Phase: N/A Priority: Normal
NCT ID: NCT00000925 Org: User:
Start: 05/31/99 End: - Due: -

Treatment Success and Failure in HIV-Infected Subjects Receiving Indinavir in Combination With Nucleoside Analogs: A Rollover Study for ACTG 320

Phase: N/A Priority: Normal
NCT ID: NCT00000885 Org: User:
Start: - End: 06/30/03 Due: 06/30/04

An HIV Vaccine Preparedness Study

Phase: N/A Priority: Normal
NCT ID: NCT00000915 Org: User:
Start: - End: - Due: -

A Randomized, Double-Blind Phase II/III Trial of Monotherapy vs. Combination Therapy With Nucleoside Analogs in HIV-Infected Persons With CD4 Cells of 200-500/mm3

Phase: N/A Priority: Normal
NCT ID: NCT00000625 Org: User:
Start: - End: 11/30/95 Due: 11/30/96

Buprenorphine Maintenance Protocol - 1

Phase: N/A Priority: Normal
NCT ID: NCT00000205 Org: User:
Start: 10/31/90 End: 09/30/93 Due: 09/30/94

A Phase I Dose Escalation Study of Synthetic Hypericin in HIV-Infected Patients With Less Than 300 CD4 Lymphocytes

Phase: N/A Priority: Normal
NCT ID: NCT00000645 Org: User:
Start: - End: 10/31/94 Due: 10/31/95

A Phase I Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Immunogenicity of HIV-1 Recombinant Envelope Glycoprotein gp160

Phase: N/A Priority: Normal
NCT ID: NCT00000745 Org: User:
Start: - End: 05/31/91 Due: 05/31/92

IV Cocaine Abuse: A Laboratory Model - 4

Phase: N/A Priority: Normal
NCT ID: NCT00000215 Org: User:
Start: - End: 12/31/01 Due: 12/31/02

A Registry of Tuberculosis Cases in the CPCRA

Phase: N/A Priority: Normal
NCT ID: NCT00000785 Org: User:
Start: 08/31/92 End: 06/30/94 Due: 06/30/95

Toward Better Outcomes in Osteoarthritis

Phase: N/A Priority: Normal
NCT ID: NCT00000425 Org: User:
Start: 07/31/96 End: 04/30/01 Due: 04/30/02

Women's Angiographic Vitamin and Estrogen Trial (WAVE)

Phase: N/A Priority: Normal
NCT ID: NCT00000555 Org: User:
Start: 08/31/96 End: 05/31/03 Due: 05/31/04

A Phase II, Comparative Study of Seroconversion of Single-Dose and Two-Dose Measles Vaccination in HIV-Infected and HIV-Uninfected Children: A Multicenter Trial of the Pediatric AIDS Clinical Trials Group

Phase: N/A Priority: Normal
NCT ID: NCT00000815 Org: User:
Start: - End: 08/31/01 Due: 08/31/02

A Randomized, Double-Blind Study of 566C80 Versus Septra (Sulfamethoxazole/Trimethoprim) for the Treatment of Pneumocystis Carinii Pneumonia in AIDS Patients

Phase: N/A Priority: Normal
NCT ID: NCT00000655 Org: User:
Start: - End: - Due: -

A Study to Evaluate the Safety and Tolerability of Zidovudine (ZDV) in Premature Infants Born to HIV-Positive Women.

Phase: N/A Priority: Normal
NCT ID: NCT00000855 Org: User:
Start: - End: 02/29/00 Due: 02/28/01

Trial of Nonpharmacologic Interventions in Elderly (TONE)

Phase: N/A Priority: Normal
NCT ID: NCT00000535 Org: User:
Start: 04/30/92 End: 03/31/97 Due: 03/31/98

Girls Health Enrichment Multi-Site Studies (GEMS)

Phase: N/A Priority: Normal
NCT ID: NCT00000615 Org: User:
Start: 08/31/99 End: 11/30/06 Due: 11/30/07

Naltrexone for Early Problem Drinkers

Phase: N/A Priority: Normal
NCT ID: NCT00000455 Org: User:
Start: - End: 09/30/02 Due: 09/30/03

Penicillin Prophylaxis in Sickle Cell Disease (PROPS)

Phase: N/A Priority: Normal
NCT ID: NCT00000585 Org: User:
Start: 08/31/83 End: 10/31/94 Due: 10/31/95

Differential Acute Tolerance Development to Effects of Nitrous Oxide - 7

Phase: N/A Priority: Normal
NCT ID: NCT00000255 Org: User:
Start: 04/30/95 End: 05/31/96 Due: 05/31/97

Controlled Clinical Trial of Antiviral Cytotoxic T Lymphocyte (CTL) Infusion Following Combination Antiretroviral Drug Therapy for Asymptomatic HIV-1 Infection

Phase: N/A Priority: Normal
NCT ID: NCT00000875 Org: User:
Start: - End: 04/30/03 Due: 04/30/04